Procurement for every material that touches the batch.
You can't swap a qualified supplier on short notice. Silkline keeps qualified sources, lot documentation, and supplier changes visible from RFQ to release.
The Challenge
Why is procurement so hard for pharmaceutical manufacturers?
In pharma, a supplier isn't just a vendor. Change the source of an API and you're typically looking at a prior approval supplement. Even an excipient grade change can need one. Sourcing decisions get locked in for years, and a disruption nobody saw coming can stop a batch.
Qualified suppliers you can't easily replace
Many critical materials have one qualified source: a specific resin, a specific stopper, a specific single-use assembly. Qualifying an alternate takes months. Until it's done, every risk on that supplier is your risk.
Supplier changes that arrive late or not at all
A supplier moves a site, swaps a raw material, or tweaks a process. Your quality agreement says they have to tell you. In practice the notice lands in one person's inbox, and quality hears about it during an investigation.
Documentation tied to every lot
Certificates of analysis, certificates of conformance, and qualification status have to line up with every lot you receive. When procurement and quality work from different records, material sits in quarantine waiting on paperwork.
Volatile lead times on single-use and packaging components
Single-use bioprocess assemblies, glass vials, and elastomeric closures have swung from weeks to many months with little warning. Without a live view of open orders against need dates, you find out when the line is already waiting.
What Goes Wrong
Where pharma procurement creates quality risk without anyone noticing.
Each of these looks like routine purchasing. They show up later as deviations, holds, and missed batches.
1. Buying from a supplier whose qualification has lapsed
The approved supplier list lives in the QMS. POs live in the ERP. Nobody cross-checks them at the moment of purchase, and a lapsed source gets an order.
2. Supplier changes discovered at incoming inspection
A change notice was sent, but it never reached quality. The first sign is a material that behaves differently, and now you're running an investigation instead of a batch.
3. Lot documents chased after receipt
The material arrives without its CoA. QC can't release it. Someone spends a week emailing the supplier while the schedule waits.
4. Single-source risk managed from memory
Everyone knows a few materials are risky. Nobody has a list. Safety stock is set by instinct until a shortage proves it wrong.
Why Silkline
How does Silkline help pharmaceutical manufacturers protect supply and quality?
One record for every material, supplier, and document, shared by procurement and quality.
Qualification status at the point of purchase
Track supplier qualification and quality agreement status in Silkline, so orders go to approved sources for approved materials, and a lapse is flagged before the PO goes out.
Supplier changes captured, not lost
Every supplier conversation lives in one shared record instead of individual inboxes. When a supplier notifies a change, quality sees it the same day.
Documentation requested with the order
Specify CoA and CoC requirements on the PO and collect them from suppliers alongside shipment details. The paperwork arrives with the material, not a week after it.
Early warning on long-lead and single-source materials
Open orders are tracked against need dates with automated supplier check-ins. When a critical material starts to drift, you know while there's still time to act.
Platform features most relevant to pharmaceuticals
Source
RFQs limited to qualified suppliers for each material
Procure
POs with document requirements and approval routing built in
Track
Need-date tracking and automated check-ins on long-lead materials
Monitor
Supplier scorecards and single-source risk visibility
Comply
Supplier qualification, quality agreements, and CoA/CoC records linked to every order and organized for audit